Pharm Test

21 cards   |   Total Attempts: 183
  

Cards In This Set

Front Back
How can drugs be cliassified ?
-Clinical Indication: antifungal, antispasmodics
-Mechanism of action: diuretics, beta-blocker, antihypertensives
-Body system: respiratory drugs, cardiovascular drugs, integumentary system drugs
Antidysrhythmics groups
Group I: fast sodium channel inhibitors, Group II: beta-adrenergic blockers, Group III: prolong cardiac repolarization, and Group IV: calcium channel blockers
Cardiac glycosides (digoxin) pharm action
Positive inotropic effect - increases contraction strength
ACE-inhibitors (catopril
Angiotensin receptor blockers (losartan)
Diuretics (furosemide, spironolactone)
PHARM ACTION
Reduce fluid retension, which decreases overstretch of myocardial muscle durring ventricular filling (reduced preload
ACE-Inhibitors (catopril)
Angiotensin receptor blockers (losartan)
Vasodilators (nitrates, hydralazine)
Aldosterone antagonist (spironlactone
PHARM ACTION
Reduce systemic BP, which improves efficiency of ventricle to expel blood (reduced afterload
Low-dose Beta-adrenergic blockers (carvedilol
PHARM ACTION
Blunt long-term sympathetic stimulation associated with worsening heart failure
B-type natriuretic peptide (nesiritide) PHARM ACTION
Augment neurohormonal response to heart failure with vasodilation; reduce fluid retention
Antidysrhythmic drugs
Ca-channel blockers
Beta-adrenergic blockers
PHARM ACTION
Converts to normal sinus rhythm, abolishes dysrhythmia, or controls rate
Nitrates
Ca-channel blockers (dilatiazem)
Beta-adrenergic blockers (propranolol)
PHARM ACTION
Coronary vasodilation and/or lessens work of the heart
Antiplatelets (aspirin)
Anticoagulants (warfarin)
Fibrinolytics (alteplase)
PHARM ACTION
Prevent or treat clot formation in coronary arteries
Antihyperlipidemics (lovastatin)
PHARM ACTION
Prevent atherosclerosis and risk for clot formation in coronary arteries
Drugs that effect Cardiac Output
Beta blockers, diuretics, CCBs
Drugs that effect Total Peripheral Resistance
ACE inhibitors, ARBs, Alpha blockers, Alpha-2-agonists, CCBs, diuretics, sympatholytics, vasodilators
Diuretics promote
the formation & excretion of urine, resulting in a loss of excess salt and water from the body by renal excretion
3 types used to treat HTN
Thiazide, loop diuretics, and potassium sparing diuretics. Thiazides are recommended as 1st-line drug therapy (for uncomplicated HTN).